BRIEF-Alexion Pharmaceuticals posts Q4 adj. earnings $1.26/shr

* Alexion reports fourth quarter and full year 2016 results and provides financial guidance for 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.